PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5665.79M
Enterprise Value 3552.29M
Trailing P/E N/A
Forward P/E 1-9.91
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)7.45
Price/Book (mrq)7.04
Enterprise Value/Revenue 36.18
Enterprise Value/EBITDA 6-6.85

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin -100.09%
Operating Margin (ttm)-98.18%

Management Effectiveness

Return on Assets (ttm)-34.84%
Return on Equity (ttm)-88.91%

Income Statement

Revenue (ttm)89.42M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)7.50%
Gross Profit (ttm)34.66M
EBITDA -80.58M
Net Income Avi to Common (ttm)-89.5M
Diluted EPS (ttm)-0.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)63.49M
Total Cash Per Share (mrq)0.48
Total Debt (mrq)14.12M
Total Debt/Equity (mrq)16.52
Current Ratio (mrq)4.33
Book Value Per Share (mrq)0.65

Cash Flow Statement

Operating Cash Flow (ttm)-71.31M
Levered Free Cash Flow (ttm)-46.67M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.30
52-Week Change 33.23%
S&P500 52-Week Change 39.67%
52 Week High 35.82
52 Week Low 32.02
50-Day Moving Average 34.75
200-Day Moving Average 33.61

Share Statistics

Avg Vol (3 month) 31.23M
Avg Vol (10 day) 31.1M
Shares Outstanding 5146.01M
Float 97.39M
% Held by Insiders 14.89%
% Held by Institutions 177.37%
Shares Short (Sep 28, 2018) 48.97M
Short Ratio (Sep 28, 2018) 45.82
Short % of Float (Sep 28, 2018) 47.52%
Short % of Shares Outstanding (Sep 28, 2018) 46.80%
Shares Short (prior month Aug 31, 2018) 49.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A